Paces Ferry Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
4,345
-78
-2% -$4.48K 0.09% 117
2026
Q1
$268K Buy
4,423
+151
+4% +$8.8K 0.11% 111
2025
Q4
$230K Buy
+4,272
New +$206K 0.09% 117
2025
Q3
– Sell
-4,515
Closed -$209K – 129
2025
Q2
$209K Sell
4,515
-296
-6% -$14.5K 0.1% 116
2025
Q1
$293K Sell
4,811
-32
-0.7% -$1.86K 0.15% 91
2024
Q4
$274K Buy
+4,843
New +$271K 0.13% 100
2020
Q4
– Sell
-1,061
Closed -$64K – 243
2020
Q3
$64K Buy
+1,061
New +$63.9K 0.06% 206

Other funds holding BMY

Paces Ferry Wealth Advisors's BMY Position: Q2 2026 in Review

Paces Ferry Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.8% in Q2 2026, selling an estimated $4.48K and leaving 4,345 shares worth $250K. The position accounts for 0.09% of the portfolio, ranked #117.

Paces Ferry Wealth Advisors first reported a position in BMY in Q3 2020 and has held it in 7 quarters since. The position peaked at $293K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Paces Ferry Wealth Advisors held 4,345 shares of Bristol-Myers Squibb worth $250K as of Q2 2026.
  • Paces Ferry Wealth Advisors sold 78 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.48K.
  • Bristol-Myers Squibb made up 0.09% of Paces Ferry Wealth Advisors's portfolio in Q2 2026, its #117 holding.
  • Paces Ferry Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 7 quarters since.
  • Paces Ferry Wealth Advisors's Bristol-Myers Squibb position peaked at $293K in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.